W L Carroll
Overview
Explore the profile of W L Carroll including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DelRocco N, Loh M, Borowitz M, Gupta S, Rabin K, Zweidler-McKay P, et al.
Leukemia
. 2024 Feb;
38(4):720-728.
PMID: 38360863
Current strategies to treat pediatric acute lymphoblastic leukemia rely on risk stratification algorithms using categorical data. We investigated whether using continuous variables assigned different weights would improve risk stratification. We...
2.
Karol S, Larsen E, Cheng C, Cao X, Yang W, Ramsey L, et al.
Leukemia
. 2017 Jan;
31(6):1325-1332.
PMID: 28096535
The causes of individual relapses in children with acute lymphoblastic leukemia (ALL) remain incompletely understood. We evaluated the contribution of germline genetic factors to relapse in 2225 children treated on...
3.
Liu Y, Fernandez C, Smith C, Yang W, Cheng C, Panetta J, et al.
Clin Pharmacol Ther
. 2017 Jan;
102(1):131-140.
PMID: 28090653
Remission induction therapy for acute lymphoblastic leukemia (ALL) includes medications that may cause hepatotoxicity, including asparaginase. We used a genome-wide association study to identify loci associated with elevated alanine transaminase...
4.
Madhusoodhan P, Lu B, Chen J, Jones C, Meyer J, Roman E, et al.
Haemophilia
. 2016 Dec;
23(2):e138-e140.
PMID: 27995737
No abstract available.
5.
Matlawska-Wasowska K, Kang H, Devidas M, Wen J, Harvey R, Nickl C, et al.
Leukemia
. 2016 Mar;
30(9):1909-12.
PMID: 26952838
No abstract available.
6.
Schultz K, Carroll A, Heerema N, Bowman W, Aledo A, Slayton W, et al.
Leukemia
. 2014 Jan;
28(7):1467-71.
PMID: 24441288
We previously reported preliminary findings that post induction imatinib mesylate (340 mg/m(2)/day), in combination with intensive chemotherapy, resulted in outcomes similar to blood and marrow transplant (BMT) for pediatric patients...
7.
Schultz K, Devidas M, Bowman W, Aledo A, Slayton W, Sather H, et al.
Leukemia
. 2014 Jan;
28(4):964-7.
PMID: 24434862
No abstract available.
8.
Morrison D, Hogan L, Condos G, Bhatla T, Germino N, Moskowitz N, et al.
Leukemia
. 2011 Aug;
26(2):271-9.
PMID: 21844871
Although the cure rate of newly diagnosed acute lymphoblastic leukemia (ALL) has improved over the past four decades, the outcome for patients who relapse remains poor. New therapies are needed...
9.
Loudin M, Wang J, Leung H, Gurusiddappa S, Meyer J, Condos G, et al.
Leukemia
. 2011 Jun;
25(10):1555-63.
PMID: 21647151
Patients with Down syndrome (DS) and acute lymphoblastic leukemia (ALL) have distinct clinical and biological features. Whereas most DS-ALL cases lack the sentinel cytogenetic lesions that guide risk assignment in...
10.
Gaynon P, Angiolillo A, Carroll W, Nachman J, Trigg M, Sather H, et al.
Leukemia
. 2009 Dec;
24(2):285-97.
PMID: 20016531
The Children's Cancer Group enrolled 13 298 young people age <21 years on 1 of 16 protocols between 1983 and 2002. Outcomes were examined in three time periods, 1983-1988, 1989-1995,...